Summary of the ZepBound Subsection (Mini-List) Dual GIP and GLP-1 receptor agonist approved for weight management Provides strong appetite suppression and craving reduction Leads to some of the largest weight loss outcomes among modern medications Improves insulin sensitivity and metabolic health Ideal for patients needing powerful, once-weekly metabolic support Why We Do Not Use Compounded Weight Loss Medications Compounded versions of semaglutide, tirzepatide, or similar medications have become widely advertised by online clinics, medspas, and cash-pay weight loss programs
Final candidacy is always determined in person
Glycemic control also gets better
The emerging role of glucagon-like peptide 1 in binge eating
115133 It is noteworthy that these data primarily derive from clinical trials in T2DM or obesity, and given the heterogeneity of metabolic disorders, caution should be exercised
Physiatrist Heidi Prather, DO, is head of the HSS Lifestyle Medicine Program, which is available for HSS patients whether or not they need surgery
